Global Minimal Residual Disease Testing Market Report 2023-2028 Featuring Key Players - Adaptive Biotechnologies, Invitae, Guardant Health, Natera, NeoGenomics, Exact Sciences, and Quest Diagnostics
August 30, 2023 04:43 ET
|
Research and Markets
Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing: Global Markets and Technologies" report has been added to ResearchAndMarkets.com's offering. The global market for...
Global MRD (Minimal Residual Disease) Testing Research Report 2023: Rising Number of Clinical Trials in Prolonged MRD-Negative Treatment Decisions Present Opportunities
July 21, 2023 04:18 ET
|
Research and Markets
Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "MRD Testing Market - Global and Regional Analysis: Focus on Technology, Target Detection, End User and Region Analysis - Analysis and Forecast,...
Global Protein Assays Market Industry Research 2023: Rigorous R&D in Proteomics and Advancements in Cancer Diagnostics Drive Growth - Competition, Opportunities and Forecasts to 2028
July 12, 2023 07:48 ET
|
Research and Markets
Dublin, July 12, 2023 (GLOBE NEWSWIRE) -- The "Protein Assays Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028 Segmented By Type, By Product, By...
Final Day to Register: Europe Circulating Biomarkers and Extracellular Vesicles Annual Conference 2023 (Rotterdam, Netherlands - June 19-20, 2023)
June 02, 2023 04:08 ET
|
Research and Markets
Dublin, June 02, 2023 (GLOBE NEWSWIRE) -- The "5th Annual Circulating Biomarkers and Extracellular Vesicles Europe 2023" conference has been added to ResearchAndMarkets.com's offering. The...
Global Next-Generation Breast Cancer Diagnostic and Screening Market to 2032: Increased Awareness Regarding Early Diagnosis of Breast Cancer Drives Growth
May 26, 2023 05:28 ET
|
Research and Markets
Dublin, May 26, 2023 (GLOBE NEWSWIRE) -- The "Next-Generation Breast Cancer Diagnostic and Screening Market - A Global Market and Regional Analysis: Focus on Technology, Cancer Sub-Type, Biomarker,...
Circulating Tumor Cells Global Market Report 2023: Widespread Adoption of CTC-Based Liquid Biopsy Boosts Growth
March 08, 2023 06:03 ET
|
Research and Markets
Dublin, March 08, 2023 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cells Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
United States Biopsy Market Report 2023: Sector to Reach $21.4 Billion by 2028 at a CAGR of 4.5%
March 03, 2023 09:13 ET
|
Research and Markets
Dublin, March 03, 2023 (GLOBE NEWSWIRE) -- The "United States Biopsy Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been...
World Liquid Biopsy Market Report 2023-2027: Market Share Assessments, Competitive Research, and Due Diligence for M&As
March 03, 2023 06:18 ET
|
Research and Markets
Dublin, March 03, 2023 (GLOBE NEWSWIRE) -- The "The World Market for Liquid Biopsy, 2023" report has been added to ResearchAndMarkets.com's offering. The World Liquid Biopsy Market, 2023,...
Global Smart In-Vitro Diagnostics (IVD) Market Research Report 2023: How Players are Jockeying for Position in a Market that is Being Created from Scratch
March 02, 2023 03:48 ET
|
Research and Markets
Dublin, March 02, 2023 (GLOBE NEWSWIRE) -- The "Smart in Vitro Diagnostics - Artificial Intelligence for IVD Markets by Application, by Technology and by User with Executive and Consultant Guides"...
Europe Biomarker Technologies Market Research Report 2022: Focus on Immunoassay, DDPCR, Next Generation Sequencing (NGS), Mass Spectrometry, DHPLC - Trends, Forecasts & Opportunities to 2028
February 09, 2023 11:58 ET
|
Research and Markets
Dublin, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The "Europe Biomarker Technologies Market, By Test Type, By Technology (Immunoassay, DDPCR, Next Generation Sequencing (NGS), Mass Spectrometry, DHPLC,...